GenEmbryomics Withdraws Nasdaq IPO Plan
30 Apr 2025
US$ 20.00
GenEmbryomics Ltd (GenEmbryomics), an Australian medical technology company backed by venture capital firm Artesian,...
Related Publications
Bertelsmann India Investments has led the US$15 m series A funding round raised by FDMS Marketplace Pvt Ltd, operator...
NIO Capital and CoStone Capital were party to the near Rmb1 bn (US$147.4 m) series C+ funding round of Volant ......
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.